tirzepatide crohn's Mirikizumab and Administered in Adult Participants With Moderately to Severely Active Disease and Obesity or Overweight (COMMIT-CD) GLP-1 with Crohn's Disease: Safety,
Pay in 4 interest-free payments of $7.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13

























